Nifty
:
21915.35
Sensex
:
72209.86
-80.50 (-0.37%)
-279.13 (-0.39%)
Nifty
Sensex
:
:
21915.35
72209.86
-80.50 (-0.37%)
-279.13 (-0.39%)

Nureca Ltd.

Medical Equipment/Supplies/Accessories

Rating :
28/99

BSE: 543264 | NSE: NURECA

NSE BSE
276.30
18-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  284.90
  •  284.95
  •  275.35
  •  278.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  19372
  •  54.16
  •  468.80
  •  253.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 276.60
  • 336.50
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 219.39
  • N/A
  • 1.40

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 63.24%
  • 0.98%
  • 33.73%
  • FII
  • DII
  • Others
  • 0.07%
  • 0.00%
  • 1.98%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 12.45
  • -19.51

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 30.43

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 4.80

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 3.63

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
22.37
27.79
-19.50%
31.35
36.78
-14.76%
21.23
25.53
-16.84%
21.23
41.05
-48.28%
Expenses
26.63
28.70
-7.21%
29.97
41.69
-28.11%
24.13
31.26
-22.81%
24.68
43.79
-43.64%
EBITDA
-4.25
-0.92
-
1.38
-4.91
-
-2.90
-5.73
-
-3.46
-2.74
-
EBIDTM
-19.02%
-3.30%
4.42%
-13.34%
-13.67%
-22.44%
-16.28%
-6.67%
Other Income
5.90
1.90
210.53%
3.20
1.89
69.31%
2.67
1.17
128.21%
2.15
1.71
25.73%
Interest
0.11
0.11
0.00%
0.08
0.10
-20.00%
0.12
0.14
-14.29%
0.10
0.29
-65.52%
Depreciation
0.59
0.60
-1.67%
0.59
0.62
-4.84%
0.58
0.61
-4.92%
0.56
0.59
-5.08%
PBT
0.95
0.27
251.85%
3.91
-3.74
-
-0.93
-5.30
-
-1.97
-1.91
-
Tax
0.78
-0.03
-
1.02
-0.85
-
-0.22
-1.17
-
-0.44
-0.50
-
PAT
0.16
0.30
-46.67%
2.89
-2.89
-
-0.71
-4.13
-
-1.53
-1.40
-
PATM
0.74%
1.08%
9.23%
-7.86%
-3.33%
-16.17%
-7.21%
-3.42%
EPS
0.17
0.30
-43.33%
2.89
-2.89
-
-0.71
-4.13
-
-1.53
-1.40
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Net Sales
96.18
111.32
255.55
213.45
99.43
61.90
20.05
Net Sales Growth
-26.66%
-56.44%
19.72%
114.67%
60.63%
208.73%
 
Cost Of Goods Sold
63.75
75.53
132.62
99.48
64.60
40.15
11.11
Gross Profit
32.43
35.79
122.92
113.97
34.82
21.74
8.94
GP Margin
33.72%
32.15%
48.10%
53.39%
35.02%
35.12%
44.59%
Total Expenditure
105.41
126.33
200.04
151.91
89.73
52.84
15.68
Power & Fuel Cost
-
0.20
0.16
0.01
0.04
0.02
0.01
% Of Sales
-
0.18%
0.06%
0.00%
0.04%
0.03%
0.05%
Employee Cost
-
16.06
9.91
4.58
3.16
0.89
0.36
% Of Sales
-
14.43%
3.88%
2.15%
3.18%
1.44%
1.80%
Manufacturing Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
General & Admin Exp.
-
7.94
9.42
3.11
3.38
0.52
0.23
% Of Sales
-
7.13%
3.69%
1.46%
3.40%
0.84%
1.15%
Selling & Distn. Exp.
-
23.36
43.68
43.32
17.94
10.63
3.91
% Of Sales
-
20.98%
17.09%
20.30%
18.04%
17.17%
19.50%
Miscellaneous Exp.
-
3.24
4.25
1.42
0.62
0.64
0.06
% Of Sales
-
2.91%
1.66%
0.67%
0.62%
1.03%
0.30%
EBITDA
-9.23
-15.01
55.51
61.54
9.70
9.06
4.37
EBITDA Margin
-9.60%
-13.48%
21.72%
28.83%
9.76%
14.64%
21.80%
Other Income
13.92
7.11
7.70
2.82
0.06
0.09
0.02
Interest
0.41
0.45
0.74
1.60
0.77
0.24
0.06
Depreciation
2.32
2.39
1.48
0.42
0.37
0.06
0.01
PBT
1.96
-10.74
60.98
62.33
8.61
8.84
4.32
Tax
1.14
-2.49
16.02
15.96
2.21
2.62
1.21
Tax Rate
58.16%
23.18%
26.27%
25.61%
25.67%
29.64%
28.01%
PAT
0.81
-8.25
44.96
46.37
6.39
6.23
3.11
PAT before Minority Interest
0.81
-8.25
44.96
46.37
6.39
6.23
3.11
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
0.84%
-7.41%
17.59%
21.72%
6.43%
10.06%
15.51%
PAT Growth
109.98%
-
-3.04%
625.67%
2.57%
100.32%
 
EPS
0.81
-8.25
44.96
46.37
6.39
6.23
3.11

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Shareholder's Funds
194.88
203.20
163.10
14.94
7.95
1.72
Share Capital
10.00
10.00
10.00
0.01
0.01
0.01
Total Reserves
184.88
193.20
153.10
13.93
6.95
0.72
Non-Current Liabilities
0.09
3.59
3.23
9.40
0.28
0.01
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.78
9.35
0.26
0.00
Long Term Provisions
0.79
0.41
0.45
0.10
0.03
0.01
Current Liabilities
8.93
45.27
23.95
9.51
15.29
5.29
Trade Payables
4.99
4.72
8.74
5.83
9.76
5.26
Other Current Liabilities
3.51
5.21
5.39
1.23
5.51
0.02
Short Term Borrowings
0.08
0.08
0.22
0.08
0.00
0.00
Short Term Provisions
0.35
35.26
9.59
2.38
0.02
0.01
Total Liabilities
203.90
252.06
190.28
33.85
23.52
7.02
Net Block
8.65
10.19
3.68
1.06
0.54
0.02
Gross Block
11.80
11.87
3.89
1.14
0.61
0.03
Accumulated Depreciation
3.15
1.69
0.20
0.08
0.06
0.01
Non Current Assets
17.29
12.84
4.08
1.09
0.55
0.02
Capital Work in Progress
0.00
0.42
0.30
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
1.40
0.27
0.10
0.03
0.00
0.00
Other Non Current Assets
7.24
1.95
0.00
0.00
0.00
0.00
Current Assets
186.61
239.23
186.20
32.76
22.97
7.00
Current Investments
59.09
33.19
0.00
0.00
0.00
0.00
Inventories
34.48
63.18
36.78
16.43
13.55
3.54
Sundry Debtors
4.29
2.89
0.22
12.90
8.86
1.69
Cash & Bank
70.97
84.35
126.69
0.07
0.11
0.07
Other Current Assets
17.79
7.62
6.58
2.00
0.46
1.70
Short Term Loans & Adv.
13.88
47.99
15.93
1.36
0.45
1.69
Net Current Assets
177.68
193.96
162.25
23.25
7.68
1.70
Total Assets
203.90
252.07
190.28
33.85
23.52
7.02

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Cash From Operating Activity
10.23
1.40
34.87
-7.92
0.31
0.10
PBT
-10.74
60.98
62.33
8.61
8.84
4.32
Adjustment
-3.48
-3.73
0.11
1.17
0.30
0.03
Changes in Working Capital
28.59
-37.90
-12.51
-17.69
-8.83
-4.26
Cash after chg. in Working capital
14.37
19.35
49.93
-7.92
0.31
0.10
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-4.15
-17.95
-15.07
-0.01
-0.01
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-16.46
-3.09
-110.04
-0.39
-0.12
-0.02
Net Fixed Assets
0.74
-7.96
-2.72
-1.08
-0.06
Net Investments
-27.65
-33.68
-0.77
-0.05
0.00
Others
10.45
38.55
-106.55
0.74
-0.06
Cash from Financing Activity
-1.51
-7.30
92.34
8.28
-0.14
-0.06
Net Cash Inflow / Outflow
-7.74
-8.99
17.17
-0.04
0.04
0.02
Opening Cash & Equivalents
8.25
17.24
0.07
0.11
0.07
0.05
Closing Cash & Equivalent
0.50
8.25
17.24
0.07
0.11
0.07

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Book Value (Rs.)
194.88
203.20
163.10
1990.71
6955.00
730.00
ROA
-3.62%
20.33%
41.38%
22.30%
40.78%
44.35%
ROE
-4.14%
24.55%
52.39%
61.23%
162.03%
426.30%
ROCE
-5.17%
33.57%
67.61%
56.70%
179.97%
255.06%
Fixed Asset Turnover
9.85
34.28
89.50
113.76
201.42
771.19
Receivable days
11.25
2.11
10.64
39.93
30.18
30.69
Inventory Days
152.88
67.53
43.16
55.02
48.92
64.42
Payable days
23.46
18.53
26.74
31.96
44.39
103.55
Cash Conversion Cycle
140.67
51.10
27.07
62.99
34.71
-8.44
Total Debt/Equity
0.00
0.00
0.01
0.70
0.06
0.00
Interest Cover
-22.87
83.30
39.89
12.14
37.38
68.55

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019

News Update:


  • Nureca’s Dr Trust recognized as ‘Well Known Trademark’ by Indian Trademark Registry
    2nd Apr 2024, 18:07 PM

    This milestone underscores Dr Trust's commitment to excellence and reinforces its standing as a frontrunner in the home healthcare and wellness industry

    Read More
  • Nureca Ltd. - Quarterly Results
    7th Feb 2024, 17:24 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.